The Biostatistics and Epidemiology Office is part of the Clinical Research Division and has been labelled an Center for Data Handling by the National Cancer Institute (INCa) since 2007.
The Biostatistics and Epidemiology Office comprises about 40 members (statisticians, MDs in public health, pharmacists-statisticians, public health intern, data-managers, health economists, etc.) and has the following main missions:
The Projects and Sponsorship Office fits into the Gustave Roussy’s goal to optimize its clinical research performance and to develop its ability to manage large national and international academic trials with high added value and to strengthen Gustave Roussy position as an expert and center of excellence to conduct pharma companies innovative trials.
Publications Etudes et Recherche en Economie de la Santé 2023-24
1. Lueza B, Aupérin A, Rigaud C, Gross TG, Pillon M, Delgado RF, Uyttebroeck A, Amos Burke GA, Zsíros J, Csóka M, Simonin M, Patte C, Minard-Colin V, Bonastre J. Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin's lymphoma. Eur J Health Econ. 2024 Mar;25(2):307-317.
A research with strong societal impact integrated with care
Research at Gustave Roussy meets society's needs related to cancer. It is integrated into care because it is in the context of care that the data on which the research is based are collected from patients, and it is for the care of patients that the results of the research are used.